Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,899.60
(
0.11%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.12
(
-0.94%
)
Bitcoin
77,462.98
(
1.49%
)
News Focus
News Focus

Replies to post #210043 on Biotech Values

Replies to #210043 on Biotech Values
icon url

JohnWayne

03/23/17 12:14 AM

#210046 RE: DewDiligence #210043

Standard dosing cycle for CTLA-4 inhibitor. True not just for MYSTIC, but just about all tremelimumab (and Yervoy) studies.